NYSE:MNK - Mallinckrodt News Headlines

Sign in or create an account to add this stock to your watchlist.
$23.18 +0.47 (+2.07 %)
(As of 03/20/2019 09:03 AM ET)
Previous Close$22.71
Today's Range$22.8559 - $23.37
52-Week Range$11.65 - $36.65
Volume3.58 million shs
Average Volume2.30 million shs
Market Capitalization$1.94 billion
P/E Ratio2.89
Dividend YieldN/A
Beta2.31

Headlines

Mallinckrodt (NYSE MNK) News Headlines

Source:
DateHeadline
Allergans Anti-Infective Gets FDA Nod for Pediatric Patients - NasdaqAllergan's Anti-Infective Gets FDA Nod for Pediatric Patients - Nasdaq
www.nasdaq.com - March 19 at 7:21 PM
Top Ranked Value Stocks to Buy for March 19th - NasdaqTop Ranked Value Stocks to Buy for March 19th - Nasdaq
www.nasdaq.com - March 19 at 7:21 PM
SunTrust Banks Begins Coverage on Mallinckrodt (MNK)SunTrust Banks Begins Coverage on Mallinckrodt (MNK)
www.americanbankingnews.com - March 19 at 5:28 PM
Canaccord Genuity Reiterates $40.00 Price Target for Mallinckrodt (MNK)Canaccord Genuity Reiterates $40.00 Price Target for Mallinckrodt (MNK)
www.americanbankingnews.com - March 19 at 2:34 PM
Mallinckrodt PLCMallinckrodt PLC
www.bloomberg.com - March 19 at 8:59 AM
New finance chief at Mallinckrodt; shares up 3%New finance chief at Mallinckrodt; shares up 3%
seekingalpha.com - March 18 at 7:37 PM
Bryan Reasons Joins Mallinckrodt as the Companys Chief Financial Officer (CFO)Bryan Reasons Joins Mallinckrodt as the Company's Chief Financial Officer (CFO)
finance.yahoo.com - March 18 at 8:31 AM
Mallinckrodts Hobart, N.Y. and St. Louis, Mo. Sites Recognized as 2019 Manufacturing Leadership Award WinnersMallinckrodt's Hobart, N.Y. and St. Louis, Mo. Sites Recognized as 2019 Manufacturing Leadership Award Winners
finance.yahoo.com - March 15 at 8:48 AM
Look Out for Big Pharma Credit Downgrades This YearLook Out for Big Pharma Credit Downgrades This Year
finance.yahoo.com - March 13 at 9:21 AM
Mallinckrodt PLC (MNK) Presents at 2019 Barclays Global Healthcare Conference (Transcript)Mallinckrodt PLC (MNK) Presents at 2019 Barclays Global Healthcare Conference (Transcript)
seekingalpha.com - March 12 at 9:50 PM
What Could Drive Mallinckrodt’s Growth in Fiscal 2019What Could Drive Mallinckrodt’s Growth in Fiscal 2019
finance.yahoo.com - March 11 at 7:22 PM
Opioid litigation concerns weigh on pharmaceutical loan borrowersOpioid litigation concerns weigh on pharmaceutical loan borrowers
finance.yahoo.com - March 11 at 7:22 PM
How Endo’s and Mallinckrodt’s Expense Control Stacks UpHow Endo’s and Mallinckrodt’s Expense Control Stacks Up
finance.yahoo.com - March 11 at 9:45 AM
Comparing Endo’s and Mallinckrodt’s Gross Margin ForecastsComparing Endo’s and Mallinckrodt’s Gross Margin Forecasts
finance.yahoo.com - March 11 at 9:45 AM
Mallinckrodt: A Cheap And Attractive Buy Opportunity In March 2019Mallinckrodt: A Cheap And Attractive Buy Opportunity In March 2019
seekingalpha.com - March 10 at 8:43 AM
Mallinckrodt PLC (MNK) Expected to Post Quarterly Sales of $599.60 MillionMallinckrodt PLC (MNK) Expected to Post Quarterly Sales of $599.60 Million
www.americanbankingnews.com - March 9 at 1:59 AM
Analysts’ Views on Endo International and MallinckrodtAnalysts’ Views on Endo International and Mallinckrodt
finance.yahoo.com - March 8 at 7:35 PM
Comparing Endo’s and Mallinckrodt’s Revenue ForecastsComparing Endo’s and Mallinckrodt’s Revenue Forecasts
finance.yahoo.com - March 8 at 7:35 PM
Endo International’s and Mallinckrodt’s EPS Growth ExpectationsEndo International’s and Mallinckrodt’s EPS Growth Expectations
finance.yahoo.com - March 8 at 7:35 PM
Mallinckrodt PLC (MNK) Expected to Announce Earnings of $1.68 Per ShareMallinckrodt PLC (MNK) Expected to Announce Earnings of $1.68 Per Share
www.americanbankingnews.com - March 7 at 11:10 PM
Mallinckrodt PLC (MNK) CEO Buys $22,650.00 in StockMallinckrodt PLC (MNK) CEO Buys $22,650.00 in Stock
www.americanbankingnews.com - March 6 at 9:17 AM
OxyContin Maker Purdue Pharmas Legal Entanglement, ExplainedOxyContin Maker Purdue Pharma's Legal Entanglement, Explained
finance.yahoo.com - March 5 at 6:42 PM
Purdue Is Preparing for a Possible Bankruptcy Amid Opioid Lawsuits - BloombergPurdue Is Preparing for a Possible Bankruptcy Amid Opioid Lawsuits - Bloomberg
www.bloomberg.com - March 5 at 9:01 AM
Mallinckrodt Presents New Data on Real-World Resource Utilization Associated with Continuation of Systemic Treatment among Patients with Cutaneous T-cell Lymphoma at 2019 American Academy of Dermatology Annual MeetingMallinckrodt Presents New Data on Real-World Resource Utilization Associated with Continuation of Systemic Treatment among Patients with Cutaneous T-cell Lymphoma at 2019 American Academy of Dermatology Annual Meeting
finance.yahoo.com - March 4 at 9:58 AM
Mallinckrodt PLC (MNK) Forecasted to Post FY2019 Earnings of $8.10 Per ShareMallinckrodt PLC (MNK) Forecasted to Post FY2019 Earnings of $8.10 Per Share
www.americanbankingnews.com - March 4 at 3:21 AM
New Enterprise Associates is raising its biggest fund yet. Here's how much it's going for.New Enterprise Associates is raising its biggest fund yet. Here's how much it's going for.
finance.yahoo.com - March 1 at 6:45 PM
Mallinckrodt PLC to Post Q1 2019 Earnings of $1.98 Per Share, Svb Leerink Forecasts (MNK)Mallinckrodt PLC to Post Q1 2019 Earnings of $1.98 Per Share, Svb Leerink Forecasts (MNK)
www.americanbankingnews.com - March 1 at 2:57 PM
Mallinckrodt (MNK) Given a $32.00 Price Target at Morgan StanleyMallinckrodt (MNK) Given a $32.00 Price Target at Morgan Stanley
www.americanbankingnews.com - March 1 at 12:56 AM
April 12th Options Now Available For Mallinckrodt (MNK)April 12th Options Now Available For Mallinckrodt (MNK)
www.nasdaq.com - February 28 at 6:47 PM
Mallinckrodt (MNK) Price Target Increased to $26.00 by Analysts at MizuhoMallinckrodt (MNK) Price Target Increased to $26.00 by Analysts at Mizuho
www.americanbankingnews.com - February 28 at 4:34 PM
Edited Transcript of MNK earnings conference call or presentation 26-Feb-19 1:30pm GMTEdited Transcript of MNK earnings conference call or presentation 26-Feb-19 1:30pm GMT
finance.yahoo.com - February 28 at 8:48 AM
Mallinckrodt PLC (MNK) Forecasted to Earn Q4 2019 Earnings of $1.68 Per ShareMallinckrodt PLC (MNK) Forecasted to Earn Q4 2019 Earnings of $1.68 Per Share
www.americanbankingnews.com - February 28 at 8:19 AM
Implied Volatility Surging for Mallinckrodt (MNK) Stock OptionsImplied Volatility Surging for Mallinckrodt (MNK) Stock Options
finance.yahoo.com - February 27 at 7:04 PM
Mallinckrodt stock up 14% on earnings beatMallinckrodt stock up 14% on earnings beat
www.marketwatch.com - February 26 at 6:28 PM
Heres Why Mallinckrodt Jumped as Much as 26.8% TodayHere's Why Mallinckrodt Jumped as Much as 26.8% Today
www.fool.com - February 26 at 6:28 PM
Mallinckrodt (MNK) Issues FY19 Earnings GuidanceMallinckrodt (MNK) Issues FY19 Earnings Guidance
www.americanbankingnews.com - February 26 at 9:37 AM
Mallinckrodt plc Reports Strong Fourth Quarter and Total Company 2018 Results, Announces 2019 Guidance and Strategic PrioritiesMallinckrodt plc Reports Strong Fourth Quarter and Total Company 2018 Results, Announces 2019 Guidance and Strategic Priorities
www.bizjournals.com - February 26 at 8:44 AM
Mallinckrodt Q4 top line up 5%Mallinckrodt Q4 top line up 5%
seekingalpha.com - February 26 at 8:44 AM
Mallinckrodt (MNK) Issues FY 2019 Earnings GuidanceMallinckrodt (MNK) Issues FY 2019 Earnings Guidance
www.americanbankingnews.com - February 26 at 7:22 AM
Mallinckrodt Q4 Earnings PreviewMallinckrodt Q4 Earnings Preview
seekingalpha.com - February 25 at 6:48 PM
Mallinckrodts Q4 Earnings PreviewMallinckrodt's Q4 Earnings Preview
finance.yahoo.com - February 25 at 6:48 PM
Mallinckrodt teams up with Transimmune in photopheresisMallinckrodt teams up with Transimmune in photopheresis
seekingalpha.com - February 25 at 9:07 AM
Mallinckrodt Announces Extracorporeal Photopheresis Research Collaboration Agreement With Transimmune AGMallinckrodt Announces Extracorporeal Photopheresis Research Collaboration Agreement With Transimmune AG
finance.yahoo.com - February 25 at 9:07 AM
Mallinckrodt Announces Extracorporeal Photopheresis (ECP) Research Collaboration Agreement With Transimmune AGMallinckrodt Announces Extracorporeal Photopheresis (ECP) Research Collaboration Agreement With Transimmune AG
finance.yahoo.com - February 25 at 9:07 AM
Mallinckrodt PLC (MNK) Receives Consensus Rating of "Hold" from BrokeragesMallinckrodt PLC (MNK) Receives Consensus Rating of "Hold" from Brokerages
www.americanbankingnews.com - February 25 at 1:24 AM
Mallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host DiseaseMallinckrodt Announces Interim Analysis Results for Therakos(R) Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease
finance.yahoo.com - February 21 at 8:59 AM
6 Low Price-to-Book Stocks for Value Investors6 Low Price-to-Book Stocks for Value Investors
finance.yahoo.com - February 21 at 8:59 AM
Mallinckrodts Therakos system successful in late-stage GvHD studyMallinckrodt's Therakos system successful in late-stage GvHD study
seekingalpha.com - February 20 at 8:48 AM
Generic-Drugs Outlook: Price Erosion to Hurt Near-Term ProspectsGeneric-Drugs Outlook: Price Erosion to Hurt Near-Term Prospects
finance.yahoo.com - February 20 at 8:48 AM
Mallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host DiseaseMallinckrodt Announces Interim Analysis Results for Therakos® Platform Phase 3 Clinical Trial in Treatment of Pediatric Patients with Steroid Refractory Acute Graft-versus-Host Disease
finance.yahoo.com - February 20 at 8:48 AM
This page was last updated on 3/20/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel